相似文献
1
Methods and issues in studies of CRE.
Virulence. 2017 May 19;8(4):453-459. doi: 10.1080/21505594.2016.1213473. Epub 2016 Jul 28.
2
Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.
Virulence. 2017 May 19;8(4):440-452. doi: 10.1080/21505594.2016.1221021. Epub 2016 Aug 9.
3
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections.
Virulence. 2017 May 19;8(4):470-484. doi: 10.1080/21505594.2017.1292196. Epub 2017 Feb 8.
4
Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.
Virulence. 2017 May 19;8(4):403-416. doi: 10.1080/21505594.2016.1207834. Epub 2016 Jul 6.
5
Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Int J Antimicrob Agents. 2019 May;53(5):657-662. doi: 10.1016/j.ijantimicag.2019.03.011. Epub 2019 Mar 14.
6
Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.
Expert Rev Anti Infect Ther. 2017 Oct;15(10):893-895. doi: 10.1080/14787210.2017.1380519. Epub 2017 Sep 21.
7
Staggering the administration of polymyxin B and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs.
Diagn Microbiol Infect Dis. 2019 Mar;93(3):261-264. doi: 10.1016/j.diagmicrobio.2018.09.014. Epub 2018 Oct 4.
8
A Triple-Disk Enrichment Method for Carbapenem-Resistant Enterobacteriaceae (CRE) Screening.
J Clin Microbiol. 2017 Dec;55(12):3557-3559. doi: 10.1128/JCM.01185-17. Epub 2017 Sep 20.
9
Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies.
Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1707-1709. doi: 10.1007/s10096-017-3010-z. Epub 2017 May 21.
10
Evaluation of a new selective agar medium for detection of carbapenem-resistant Enterobacteriaceae.
Diagn Microbiol Infect Dis. 2019 Dec;95(4):114882. doi: 10.1016/j.diagmicrobio.2019.114882. Epub 2019 Aug 7.
引用本文的文献
1
Seven-year change of prevalence, clinical risk factors, and mortality of patients with carbapenem-resistant bloodstream infection in a Chinese teaching hospital: a case-case-control study.
Front Microbiol. 2025 Mar 19;16:1531984. doi: 10.3389/fmicb.2025.1531984. eCollection 2025.
2
Risk factors for carbapenem-resistant infections in Intensive Care Units: a multicentre case-control study with a competing-risks analysis.
J Prev Med Hyg. 2024 Jan 1;64(4):E405-E410. doi: 10.15167/2421-4248/jpmh2023.64.4.2110. eCollection 2023 Dec.
3
Under the Hood: The Scientific Leadership, Clinical Operations, Statistical and Data Management, and Laboratory Centers of the Antibacterial Resistance Leadership Group.
Clin Infect Dis. 2023 Oct 16;77(Suppl 4):S288-S294. doi: 10.1093/cid/ciad529.
4
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
Eur J Clin Microbiol Infect Dis. 2023 May;42(5):529-541. doi: 10.1007/s10096-023-04578-w. Epub 2023 Mar 1.
5
A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: A case-case-control study in Ethiopian children.
PLoS Negl Trop Dis. 2022 Jun 6;16(6):e0010508. doi: 10.1371/journal.pntd.0010508. eCollection 2022 Jun.
6
Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria.
Clin Microbiol Infect. 2021 Jan 13;27(5):687-96. doi: 10.1016/j.cmi.2021.01.004.
7
Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol.
BMJ Open. 2020 May 5;10(5):e030608. doi: 10.1136/bmjopen-2019-030608.
8
Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study.
BMC Infect Dis. 2019 Oct 7;19(1):830. doi: 10.1186/s12879-019-4461-x.
9
A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa.
PLoS One. 2019 Sep 24;14(9):e0222675. doi: 10.1371/journal.pone.0222675. eCollection 2019.
10
Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam.
PLoS One. 2019 May 8;14(5):e0215666. doi: 10.1371/journal.pone.0215666. eCollection 2019.
本文引用的文献
1
Difficulties in demonstrating superiority of an antibiotic for multidrug-resistant bacteria in nonrandomized studies.
Clin Infect Dis. 2014 Oct 15;59(8):1142-7. doi: 10.1093/cid/ciu486. Epub 2014 Jun 30.
2
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.
Emerg Infect Dis. 2014 Jul;20(7):1170-5. doi: 10.3201/eid2007.121004.
3
Hospital-acquired infections--appropriate statistical treatment is urgently needed!
Int J Epidemiol. 2013 Oct;42(5):1502-8. doi: 10.1093/ije/dyt111. Epub 2013 Sep 14.
4
Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.
Clin Microbiol Rev. 2013 Apr;26(2):289-307. doi: 10.1128/CMR.00001-13.
5
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14. doi: 10.1086/668770. Epub 2012 Nov 27.
6
Competing risks and multistate models.
Clin Cancer Res. 2013 Jan 1;19(1):12-21. doi: 10.1158/1078-0432.CCR-12-1619. Epub 2012 Nov 21.
7
Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias.
J Clin Epidemiol. 2012 Nov;65(11):1171-80. doi: 10.1016/j.jclinepi.2012.04.008.
8
Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.
J Am Coll Surg. 2012 May;214(5):747-55. doi: 10.1016/j.jamcollsurg.2012.01.040. Epub 2012 Mar 13.
9
Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients.
J Hosp Infect. 2011 Jun;78(2):86-91. doi: 10.1016/j.jhin.2011.02.003. Epub 2011 Apr 9.
10
Nosocomial infection, length of stay, and time-dependent bias.
Infect Control Hosp Epidemiol. 2009 Mar;30(3):273-6. doi: 10.1086/596020.
Zotero 插件